NASDAQ:TRVI

Trevi Therapeutics Stock Forecast

etoro logo Buy TRVI
*Your capital is at risk
$18.18
+1.41 (+8.41%)
At Close: Jul 21, 2026
AI Analysis AI Analysis of TRVI AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add TRVI to Watchlist?
Some Reasons Why To Add TRVI:
  • +159.7% price growth over the last year
  • Low bankruptcy risk (Altman Z-Score: 199.00)
  • Bullish trend confirmed on both short and long timeframes
PDF

On Tuesday, Trevi Therapeutics Inc. stock price gained an impressive 8.41%
(Updated on Jul 21, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jun 12, 2026 Gain 27.94%

The Trevi Therapeutics Inc. stock price gained 8.41% on the last trading day (Tuesday, 21st Jul 2026), rising from $16.77 to $18.18. During the last trading day the stock fluctuated 7.35% from a day low at $17.01 to a day high of $18.26. The price has fallen in 6 of the last 10 days and is down by -6.77% for this period. Volume fell on the last day by -631 thousand shares and in total, 2 million shares were bought and sold for approximately $40.16 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 33.16% during the next 3 months and, with a 90% probability hold a price between $20.80 and $27.07 at the end of this 3-month period.

TRVI Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -6.77%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). The Trevi Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $17.71 and $16.51. A breakdown below any of these levels will issue sell signals. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Trevi Therapeutics Inc. stock

Trevi Therapeutics Inc. finds support from accumulated volume at $18.15 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.25 between high and low, or 7.35%. For the last week, the stock has had daily average volatility of 10.49%.

Our recommended stop-loss: $17.29 (-4.89%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 10 days ago.)

Trading Expectations (TRVI) For The Upcoming Trading Day Of Wednesday 22nd

For the upcoming trading day on Wednesday, 22nd we expect Trevi Therapeutics Inc. to open at $17.82, and during the day (based on 14 day Average True Range), to move between $17.53 and $18.83, which gives a possible trading interval of +/-$1.30 (+/-7.44%) up or down from last closing price. If Trevi Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 7.44% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $18.15 (0.17%) than the resistance at $18.65 (2.59%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Trevi Therapeutics Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Trevi Therapeutics Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 1.918 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 22, 2026 - $17.82 ( 2.00%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

TRVI Performance

Trading levels for TRVI

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 19.07 4.88%
R2 18.59 2.25%
R1 18.29 0.628%
Price 18.18
S1 17.34 -4.63%
S2 17.04 -6.25%
S3 16.57 -8.87%

Accumulated Volume Support & Resistance Levels

Level Price
R3 19.50 7.26%
R2 19.07 4.90%
R1 18.65 2.59%
Price 18.18
S1 18.15 -0.165%
S2 18.00 -0.99%
S3 17.52 -3.63%

FAQ

What is the symbol for Trevi Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Trevi Therapeutics Inc. is TRVI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Trevi Therapeutics Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Trevi Therapeutics Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

How to buy Trevi Therapeutics Inc. Stock?
Trevi Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Trevi Therapeutics Inc. Stock.

What's the current price of Trevi Therapeutics Inc. Stock?
As of the end of day on the Jul 21, 2026, the price of an Trevi Therapeutics Inc. (TRVI) share was $18.18.

What is the 52-week high and low for Trevi Therapeutics Inc. Stock?
The 52-week high for Trevi Therapeutics Inc. Stock is $20.15 and the 52-week low is $6.55.

What is the market capitalization of Trevi Therapeutics Inc. Stock?
As of the Jul 21, 2026, the market capitalization of Trevi Therapeutics Inc. is 2.581B.

When is the next earnings date for Trevi Therapeutics Inc.?
The upcoming earnings date for Trevi Therapeutics Inc. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT TREVI THERAPEUTICS INC.
Trevi Therapeutics
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis. It has a license agreement with Endo P...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
3.35% Jul 13
JLL
$299.78
8.73% Jun 24
NMRK
$15.02
3.26% Jun 24
NESR
$25.07
8.62% Jun 23
CAG
$13.43
9.20% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE